MedTrace Logo

Colorectal Cancer Screening Validation Study

NCT00720993 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2009-04-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the gene expression patterns from colorectal mucosal cells collected through the use of a standard anoscope and cytology brush. Patients will include those scheduled for routine colonoscopy procedures and those with confirmed colorectal cancer.

Conditions

  • Colorectal Cancer Screening

Sponsors & Collaborators

  • BiotechNiks / Molecular Medicine Research Institute

    collaborator UNKNOWN

  • IntelliGeneScan, Inc.

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00720993 on ClinicalTrials.gov